How to Choose Validation Software: Scorecard and Demo Tests

How do you choose validation software for GxP systems?

Compare vendors using a risk-weighted scorecard, then test their software with a requirement change, a failed OQ step and an evidence export. Validate the rollout plan and total cost before deciding.

Do not start a validation software evaluation with a polished demo of a passing test. Give each vendor the same awkward scenario: a requirement changes after an OQ test has already been approved.

A vendor scorecard for pharma CSV teams

Score each criterion 0 (not shown), 1 (partial or manual workaround) or 2 (demonstrated end to end). Multiply the weight by score / 2. The maximum total is 100. These suggested weights are an evaluation aid, not a regulatory rating.

Evaluation criterion	Weight	Your score
Requirement, risk and test links	25	0 / 1 / 2
Execution and retrievable evidence	25	0 / 1 / 2
Deviations, changes and retests	20	0 / 1 / 2
Access, approvals and record controls	20	0 / 1 / 2
Implementation and total cost	10	0 / 1 / 2

Example calculation: A score of 1 for a criterion weighted 20 contributes 10 points. Agree on pass/fail deal-breakers separately; a high total should not offset an unacceptable data-integrity gap.

Three demo tasks that reveal more than a feature list

Task 1: Change a requirement after testing

Ask the vendor to revise a fictional URS-012 linked to an already executed OQ-04. Look for version history, affected-test identification, an impact decision and a record of who approved that decision.

Task 2: Fail a test and retest it

Record a failed OQ step, create deviation DEV-04, document the investigation and rerun the affected step. Both the original failure and later retest must remain retrievable.

Task 3: Prove the record can be reviewed

Use an authorized user to approve the completed test and export the record. Check identity, date/time, signature meaning where applicable, audit information, evidence links and readable output.

Implementation questions that affect the real cost

Validation responsibility: What supplier evidence is provided, and what must your team verify for its own intended use and configuration?
Migration: How will current URS, protocols, signatures and open deviations move, and which historical records remain in the old system?
Security and operations: How do access roles, SSO, backups, restoration, retention and vendor updates work in practice?
Integration: Are QMS, ERP or LIMS links native, configured, file-based or custom work requiring additional validation?
Commercial terms: What is the full per-user cost for your team, plus onboarding, training, support and any integration or migration work?

Two claims worth challenging

“Pre-validated” is not a substitute for your intended-use assessment. Vendor IQ/OQ evidence can be helpful, but the regulated user must establish that its chosen configuration and processes are suitable. Likewise, a GAMP 5 software category is not itself a complete GxP risk assessment; test effort should follow intended use and risk, not a category number alone.

EU GMP Annex 11 sets a risk-based expectation for computerized GMP systems. The FDA February 2026 CSA guidance has a specific medical-device production and quality-management-system software scope; do not present it as a universal pharmaceutical requirement.

Use the scorecard with GoVal or any other vendor

GoVal describes support for requirements, risk assessment, IQ/OQ/PQ execution, deviations, approvals and a live RTM. Run the same three demo tasks against GoVal and competing products, and ask for a written implementation scope. For a category comparison, see CSV software versus document management systems.

Frequently Asked Questions

What should a CSV software vendor prove in a live demo?

Ask the vendor to change one requirement after a test has been executed, record a failed test with a linked deviation and export the full evidence chain. Those demonstrations reveal workflow controls, traceability and record integrity more clearly than a feature checklist.

Does a vendor-provided IQ/OQ package mean the platform needs no validation by the customer?

No. Supplier documentation can support assurance, but the regulated organization remains responsible for assessing the platform’s intended use, configuration, risks and applicable controls. Ask for the supplier package and a clear division of validation responsibilities.

How should we compare validation software pricing?

Compare total cost for the same number of users and functions: licensing, onboarding, configuration, migration, integrations, training, support and ongoing administration. GoVal advertises per-user pricing; confirm included services and the quote for your actual user roles and deployment scope.

Do pharmaceutical companies have to follow FDA’s February 2026 CSA guidance?

That FDA guidance addresses computer software assurance for medical-device production and quality management system software. It is not a universal pharmaceutical CSV rule. Pharma teams should apply their own relevant GxP requirements and justified risk-based validation procedures.

What is the most important red flag in a validation software demo?

A vendor who cannot show what happens when a requirement changes or a test fails. Attractive templates and electronic signatures are useful, but the record must preserve earlier versions, deviations, actual results and approval history in a form your team can review.

Use your scorecard in a GoVal demo

Bring one requirement change and one failed test case to evaluate the workflow.

Book a Free Demo